Administration of Cathepsin B inhibitor halfway through the worms' reproductive period, could extend the worms' egg quality, revealed study.
"One of the most important characteristics of ageing is the loss of reproductive ability in mid-adulthood," said Coleen Murphy, Professor at the Princeton University in the US.
Infertility
Infertility is a condition wherein couples fail to achieve pregnancy or if the woman has been unable to carry a pregnancy that results in a live birth.
Advertisement
‘Novel drug that extends egg viability in worms has been identified. The new finding could potentially extend a woman's fertility by three to six years.’
Tweet it Now
"As early as the mid-30s, women start to experience declines in fertility, increased rates of miscarriage and maternal age-related birth defects. All of these problems are thought to be caused by declining egg quality, rather than a lack of eggs," Murphy added.
The team used a microscopic worm, Caenorhabditis elegans (C.elegans), as they share many of the genes as humans, including longevity genes.
They found that a group of proteins called Cathepsin B proteases "downregulate", or lead to lower-quality oocytes (unfertilised eggs), as one ages.
![In Vitro Fertilization (IVF)]( "In Vitro Fertilization (IVF)")
Encyclopedia section of medindia gives a brief introduction to infertility and reproduction
In the study, published in the journal Current Biology, when the team administered the Cathepsin B inhibitor halfway through the worms' reproductive period, they found that even a late administration of the drug could extend the worms' egg quality.
Another experiment that knocked out the cathepsin B genes entirely succeeded in extending worms' fertility by about 10 per cent.
If applied to humans, Nicole Templeman from the varsity said, "It could be a three- to six-year extension of your reproductive period".
Reproductive decline is a hallmark of ageing, but despite its prevalence, interventions to slow the loss of reproductive capacity are lacking, researchers said.
However, the cathepsin B inhibitor is nowhere near ready for testing in humans, Murphy said, yet it could one day do something mid-reproduction to improve the rest of reproduction.
Source: IANS
They found that a group of proteins called Cathepsin B proteases "downregulate", or lead to lower-quality oocytes (unfertilised eggs), as one ages.
In Vitro Fertilization (IVF)
Encyclopedia section of medindia gives a brief introduction to infertility and reproduction
Advertisement
In the study, published in the journal Current Biology, when the team administered the Cathepsin B inhibitor halfway through the worms' reproductive period, they found that even a late administration of the drug could extend the worms' egg quality.
Another experiment that knocked out the cathepsin B genes entirely succeeded in extending worms' fertility by about 10 per cent.
If applied to humans, Nicole Templeman from the varsity said, "It could be a three- to six-year extension of your reproductive period".
Reproductive decline is a hallmark of ageing, but despite its prevalence, interventions to slow the loss of reproductive capacity are lacking, researchers said.
However, the cathepsin B inhibitor is nowhere near ready for testing in humans, Murphy said, yet it could one day do something mid-reproduction to improve the rest of reproduction.
Source: IANS
Quiz on Infertility
Obesity negatively affects fertility in females. Find out why fat women have lesser chances of falling pregnant by participating in the following quiz.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.